Mounjaro 5 mg solution for injection in vial

DRUG2 trials

Sponsors

Ospedale San Raffaele S.r.l., UZ Leuven

Conditions

Hormone Receptor positive postmenopausal breast cancerWolfram syndrome type 1

Phase 2

Towards a personalized precision medicine in rare disease: tirzepatide (a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist) monotherapy in patients with Wolfram syndrome type 1.

Active, not recruitingCTIS2024-514909-64-00

Ospedale San Raffaele S.r.l.Wolfram syndrome type 1

Start: 2024-05-16Target: 10Updated: 2024-08-13

Clinical Study of Local and Systemic biological Impact of GLP1/GIP-Receptor Agonists in patients with Breast Cancer: The CLARA trial

Not yet recruitingCTIS2026-525820-76-00

UZ LeuvenHormone Receptor positive postmenopausal breast cancer

Target: 168Updated: 2026-08-31